These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 10632041

  • 1. Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA).
    Chappell LL, Rogers BE, Khazaeli MB, Mayo MS, Buchsbaum DJ, Brechbiel MW.
    Bioorg Med Chem; 1999 Nov; 7(11):2313-20. PubMed ID: 10632041
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins.
    Chappell LL, Ma D, Milenic DE, Garmestani K, Venditto V, Beitzel MP, Brechbiel MW.
    Nucl Med Biol; 2003 Aug; 30(6):581-95. PubMed ID: 12900284
    [Abstract] [Full Text] [Related]

  • 3. Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts.
    Roberson PL, Yokoyama S, Rogers BE, Buchsbaum DJ.
    Cancer Biother Radiopharm; 2003 Apr; 18(2):239-47. PubMed ID: 12804050
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb.
    Chappell LL, Dadachova E, Milenic DE, Garmestani K, Wu C, Brechbiel MW.
    Nucl Med Biol; 2000 Jan; 27(1):93-100. PubMed ID: 10755652
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics.
    Chong HS, Garmestani K, Ma D, Milenic DE, Overstreet T, Brechbiel MW.
    J Med Chem; 2002 Aug 01; 45(16):3458-64. PubMed ID: 12139456
    [Abstract] [Full Text] [Related]

  • 6. Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agents.
    Safavy A, Buchsbaum DJ, Khazaeli MB.
    Bioconjug Chem; 1993 Aug 01; 4(3):194-8. PubMed ID: 8324008
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of a new bifunctional chelating agent for the preparation of radioimmunoconjugates.
    Somayaji VV, Guay V, Peng Z, Sykes TR, Noujaim AA.
    Q J Nucl Med; 1995 Dec 01; 39(4):300-10. PubMed ID: 8624793
    [Abstract] [Full Text] [Related]

  • 9. Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates.
    Schott ME, Schlom J, Siler K, Milenic DE, Eggensperger D, Colcher D, Cheng R, Kruper WJ, Fordyce W, Goeckeler W.
    Cancer; 1994 Feb 01; 73(3 Suppl):993-8. PubMed ID: 8306291
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A convenient synthesis of bifunctional chelating agents based on diethylenetriaminepentaacetic acid and their coordination chemistry with yttrium(III).
    Cummins CH, Rutter EW, Fordyce WA.
    Bioconjug Chem; 1991 Feb 01; 2(3):180-6. PubMed ID: 1932217
    [Abstract] [Full Text] [Related]

  • 12. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
    Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti PS.
    Nucl Med Biol; 2010 Jan 01; 37(1):57-65. PubMed ID: 20122669
    [Abstract] [Full Text] [Related]

  • 13. Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu.
    Mohsin H, Jia F, Sivaguru G, Hudson MJ, Shelton TD, Hoffman TJ, Cutler CS, Ketring AR, Athey PS, Simón J, Frank RK, Jurisson SS, Lewis MR.
    Bioconjug Chem; 2006 Jan 01; 17(2):485-92. PubMed ID: 16536481
    [Abstract] [Full Text] [Related]

  • 14. DOTAGA-anhydride: a valuable building block for the preparation of DOTA-like chelating agents.
    Bernhard C, Moreau M, Lhenry D, Goze C, Boschetti F, Rousselin Y, Brunotte F, Denat F.
    Chemistry; 2012 Jun 18; 18(25):7834-41. PubMed ID: 22615050
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
    Chong HS, Milenic DE, Garmestani K, Brady ED, Arora H, Pfiester C, Brechbiel MW.
    Nucl Med Biol; 2006 May 18; 33(4):459-67. PubMed ID: 16720237
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
    Stein R, Govindan SV, Chen S, Reed L, Richel H, Griffiths GL, Hansen HJ, Goldenberg DM.
    J Nucl Med; 2001 Jun 18; 42(6):967-74. PubMed ID: 11390564
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides.
    Garmestani K, Yao Z, Zhang M, Wong K, Park CW, Pastan I, Carrasquillo JA, Brechbiel MW.
    Nucl Med Biol; 2001 May 18; 28(4):409-18. PubMed ID: 11395314
    [Abstract] [Full Text] [Related]

  • 19. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for Pancreatic Cancer.
    Aghevlian S, Lu Y, Winnik MA, Hedley DW, Reilly RM.
    Mol Pharm; 2018 Mar 05; 15(3):1150-1159. PubMed ID: 29314858
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, conjugation, and radiolabeling of a novel bifunctional chelating agent for (225)Ac radioimmunotherapy applications.
    Chappell LL, Deal KA, Dadachova E, Brechbiel MW.
    Bioconjug Chem; 2000 Mar 05; 11(4):510-9. PubMed ID: 10898572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.